Case Name: THERASENSE, INC. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellants, v. BECTON, DICKINSON AND COMPANY, and Nova Biomedical Corporation, Defendants-Cross Appellants; Therasense, Inc. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellees, v. Becton, Dickinson and Company, and Nova Biomedical Corporation, Defendants-Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2009-01-23
Citations: 329 F. App'x 276
Docket Number: Nos. 2009-1008 to 2009-1010, 2009-1034 to 2009-1037, 2009-1050
Parties: THERASENSE, INC. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellants, v. BECTON, DICKINSON AND COMPANY, and Nova Biomedical Corporation, Defendants-Cross Appellants. Therasense, Inc. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellees, v. Becton, Dickinson and Company, and Nova Biomedical Corporation, Defendants-Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 329
Pages: 276–277

Head Matter:
THERASENSE, INC. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellants, v. BECTON, DICKINSON AND COMPANY, and Nova Biomedical Corporation, Defendants-Cross Appellants. Therasense, Inc. (now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories, Plaintiffs-Appellees, v. Becton, Dickinson and Company, and Nova Biomedical Corporation, Defendants-Appellants.
Nos. 2009-1008 to 2009-1010, 2009-1034 to 2009-1037, 2009-1050.
United States Court of Appeals, Federal Circuit.
Jan. 23, 2009.

Opinion:
ON MOTION
ORDER
Becton, Dickinson and Company and Nova Biomedical Corporation move without opposition to voluntarily dismiss their appeal 2009-1050.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The motion is granted.
(2) All sides shall bear their own costs for 2009-1050.
(3) The revised official caption for 2009-1008 et al. is reflected above.